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Abstract
Integration into the host genome is an essential step in the HIV-1 life cycle. However, the host genome sequence that is
favored by HIV-1 during integration has never been documented. Here, we report that CD27, a T cell activation gene,
includes a sequence that is a target for in vitro HIV-1 cDNA integration. This sequence has a high affinity for integrase, and
the target nucleotides responsible for this higher affinity were identified using a crystal microbalance assay. In experiments
involving a segment of the CD27 gene, integration converged in the target nucleotides and flanking sequence DNA,
indicating that integration is probably dependent upon the secondary structure of the substrate DNA. Notably, decoy
modified CD27 sequence DNAs in which the target nucleotides were replaced suppressed integration when accompanying
the original CD27 sequence DNA. Our identified CD27 sequence DNA is useful for investigating the biochemistry of
integrase and for in vitro assessment of integrase-binding inhibitors.
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Introduction
After infection by the human immunodeficiency virus (HIV)-l
retrovirus, DNA synthesis begins in the cytoplasm of the infected
cell and may be completed before or after entry into the nucleus.
Integrase, which is encoded by the retroviral genome, cleaves the
viral DNA termini in preparation for attachment of the proviral
DNA to the host DNA. In the cytoplasm, the viral DNA forms a
nucleoprotein complex and enters the nucleus. The site of
retrovirus integration into the host DNA has long been believed
to be random.
The vast majority of retroviral integration studies published to
date have involved infection of cultured cells with retroviruses
followed by identification of the sites of integration into the host
cell genome. Retroviral integration into the host genome is not
an entirely random process, and the integration site preference
varies among retroviruses. There are reports that active genes
are the preferential targets of HIV integration [1]. A recent
study reported that integration in resting CD4+ T cells occurs
more often in regions that may be suboptimal for proviral gene
expression [2]. Studies of HTLV-1 integration sites in human
HeLa cells have shown that HTLV-1 does not specifically target
transcription units or transcription start sites [3]. On the other
hand, weak palindromic sequences are a common feature of the
sites targeted by retroviruses [4]. The tendency of integrase to
form dimers or tetramers is consistent with a preference for
integration at palindromic sequences. Although available
evidence suggests that integration of retroviruses into the host
genome is a non-random process, the actual target DNA
sequence has not been reported [5,6]. Here, we report the
sequence of the DNA segment within the coding region of the
human CD27 gene as determined through in vitro analysis of
HIV-1 integration [7].
A thorough analysis of previously reported HIV-1 T cell
genome integration sites found in Genbank revealed that in
human genes most integration sites are located in noncoding
regions and that integration into coding regions is rare. We
found that CD27 is one of the few genes in which HIV-1
integrates into the coding region. The CD27 gene is involved in
T cell activation; therefore, integration into this gene may
influence differentiation of host T cells by altering expression of
this gene. Schroeder et al. reported that HIV-1 prefers to
integrate into transcriptional activation genes [1]. We hypoth-
esized that HIV-1 integration into the T cell genome occurs
during transcriptional activation of the CD27 gene. By
characterizing the features of the integration sequence, we
may enhance understanding of the integration process. Because
we found that the CD27 sequence segment into which HIV-1
integrates includes a palindromic feature, which was anticipated
in a previous report, we utilized a biophysical technique, the
quartz crystal microbalance (QCM) assay, to examine the
affinity of integrase for this sequence segment. Integration into
the CD27 segment target sequence was assessed using an in vitro
integration assay.
PLOS ONE | www.plosone.org 1 November 2012 | Volume 7 | Issue 11 | e49960
Materials and Methods
Identification of the Integration Site in CD27 Locus
HIV-1 integration sites were meta-analyzed using previously
reported sites in the DNA of HIV-1–infected cells. Analysis of
Homo sapiens PAC clone RP11-102E24 revealed that HIV-1
integrates into the CD27 locus in the genome of HIV-1–infected
clone SupS1 human lymphoma T cells [Genbank Accession No.
AF038363] [6,8]. The integration site was identified in the first
intron located between the first and second exons of CD27.
In vitro Integration
In vitro integration was assessed essentially according to a
previously reported protocol [9]. Briefly, 150 ng of U39-R-U59-
U39-R-U59 tandem LTR HIV-1 cDNA was added to 50 ng of
recombinant HIV-1 integrase in 10 mL of binding buffer and
incubated for 1 h at 30uC. The binding buffer consisted of 1-
0.1 mM MgCl2, 80 mM potassium glutamate, 10 mM mercapto-
ethanol, 10% DMSO, and 35 mM MOPS (pH 7.2). The target
human CD27 DNAwas ligated into circular pCR2.1 TOPO vector
plasmidDNA (Invitrogen, Carlsbad, CA), and 500 ng of the ligation
product DNA was used as the target DNA for the assay. Truncated
target DNA or target DNAwith deleted nucleotides was also ligated
into circular pCR2.1 TOPO vector plasmid DNA. HIV-1 integrase
was kindly provided byDr.TomokazuYoshinaga [10]. The pCR2.1
plasmid containing integrated HIV-1 proviral DNA was used to
transform E. coli cells, from which the plasmid DNA was
subsequently extracted and sequenced.
The sequence of the target DNA was modified in several ways
for the in vitro integration assay. Nucleotides within the target
segment and nucleotides in the presumed DNA stem were
replaced. The details of target sequence and the replacement
nucleotides were represented in text. The percentage of integra-
tion was estimated by determining the copy number of the
products of integration into the target DNA compared to the copy
number of the products of integration into the whole-sequence
DNA (i.e., the target DNA plus the plasmid), according to
previously reported methods [7,9,11]. First, the number of E. coli
colonies exhibiting integration into the target segment was
determined. Second, the number of E. coli colonies exhibiting
integration into the whole-sequence DNA was determined. The
ratio of the former count to the latter count was considered the
percentage of integration into the target segment. For enhance-
ment of integration efficiency, a 378-bp target DNA consisting of 6
repeats of the 63-bp CD27 sequence was utilized following ligation
to the pCR2.1 TOPO vector plasmid DNA that was 3.9-kb pairs
long. One repeat CD27 sequence was not sufficient for in the
present in vitro integration study, probably because the target
segment was too short to be recognized by integrase.
Quartz Crystal Microbalance (QCM) Assay
A quartz crystal microbalance assay was used to evaluate the
affinity of integrase for the target DNA. Changes in the frequency
were monitored following the binding of 50 ng of integrase to
200 ng of target DNA in a terminal crystal oscillator. The
oscillator consisted of an electrode equipped at both sides with an
AT-angle cut crystal. Upon application of an alternating electric
field, oscillation of the target DNA-binding electrode in the
direction of horizontal shear occurs on the crystal surface
(thickness-shear-mode resonator). The relationship between the
mass of the DNA deposited on the electrode and the frequency of
oscillation is represented by the Sauerbrey equation (*), which
shows that the frequency decreases as the mass of material
deposited increases:
df ~{2f0
2dm= (r1=2mA) ð Þ
The left side of the equation (df) represents the change in the
frequency, where f0 represents the resonant frequency; r
represents the density of the crystal; represents the shear stress;
dm represents the change in the mass associated with integrase
binding; and A represents the active area of the electrode.
Therefore, the amount of integrase bound to the target DNA
segment could be compared to that bound to the modified target
DNA by determining the change in oscillation frequency.
Thermodynamic Analysis
DNA folding was predicted using the m-fold web program
(http://mfold.bioinfo.rpi.edu/cgi-bin/dna-form1.cgi) [12]. The
biochemical parameter values used in the calculations will be
described later.
Statistical Analysis
The statistical significance of differences was ascertained
through the use of unpaired t-tests with SPSS statistical software
(SPSS, Chicago, IL, USA). A P value , 0.01 was considered to be
statistically significant.
Results
Evaluation of in vitro Integration Efficiency and Selectivity
for Focal Dinucleotides
Previous report frequently utilized artificial DNA sequences or
E. coli-derived and non-human artificial sequence [9]. A thorough
analysis of HIV-1 integration sites accessed from Genbank was
performed to identify the coding region of the CD27 gene
sequence. Most of the HIV-1 integration sites described in
Genbank are located in noncoding regions. There are few
integration sites within the coding regions of genes. We used a
previously reported assay protocol for the in vitro evaluation of
integration selectivity as the basis for our analysis (Fig. 1A) [7,9]. In
the current study, we modified the protocol further by omitting the
PCR reaction and using the actual human CD27 gene as the
target DNA sequence (Fig. 1B) [7,11].
A 378-bp target DNA consisting of 6 repeats of the 63-bp CD27
sequence 59-CTGCCCTCTTCAAGGTGGTGCCTCCCCA-
CAGCT:GCAGGATTTCCCTCCTTGCTTGAGCTCAG-39
was utilized as the target sequence. The integration site is denoted
by ‘‘:’’ in the above sequence, and the 5 bases duplicated by HIV-1
integration are shown in italics. The underlined bases
CTGCCCTC vs. GAGCTCAG and CAAGGTGGTGC vs.
GCA &CCTCCTTG were palindromic with each other.
Integration sites in in vitro integration assay were localized within
the T: GCA site (Fig. 2A, indicated by a shaded box). As a result,
the ratio of the percentage of integration into the target sequence
to that of integration into the whole substrate DNA (plasmid plus
target sequence) was approximately 3.2 times greater than the
percentage obtained in an assay using random sequences (10.5%;
P , 0.01 vs. random), which was nearly equivalent to the ratio of
the percentage of integration into the target 360-bp DNA to that
of integration into the whole 3.9-kb DNA.
Subsequently, an in vitro integration assay using the target CD27
gene in which the T: GCA sequence was replaced with GACT
was then performed (Fig. 2B and C, ‘‘replaced i’’). The percent
integration into the replaced i-target segment was significantly
lower than the percent integration into the native CD27 sequence
DNA (**P , 0.01, vs. native; Fig. 2C). The sequence 59-
Target Sequence of HIV-1 Integration
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CACCCCAGTTCAAGGTGGTGCCTCCCCACAGCT:G-
CAGGATTTCCCTCCTTGCTTGAGCTCAG-39 was also eval-
uated using this assay. The underlined bases were replaced in
order to disrupt the palindrome (Fig. 2B and C, ‘‘replaced ii’’).
Disruption resulted in a significant reduction in the integration
percentage relative to the native sequence (***P , 0.01 vs. native;
Fig. 2C). Another replaced sequence, 59-
CTGCCCTCTTCAAGGTGGTGCCTCCCCACAGCT:G-
CAGGATTTCCCTCCTTGCTTGTCCTATC-39, within the
target sequence (see Fig. 2B) (replaced ‘‘iii’’) also resulted in a
significant reduction in the integration percentage, due to
disruption of the palindrome sequence motif (*P , 0.01 vs.
native; Fig. 2D).
Affinity of Viral Integrase for Target Sequences
Quartz crystal microbalance (QCM) technology was applied to
measure the affinity of viral integrase for host CD27 DNA.
Integrase binding activity was evaluated by determining the weight
(ng) of integrase bound to the oscillator-detection sensor (Fig. 3A).
In addition, the 59-T:GCA-39 sequences in the repeat unit
segments were removed and replaced (‘‘replaced i and ii) and
the resulting products were examined using the assay. The weight
of integrase that bound to the replaced i modified DNA was lower
than the weight of integrase that bound to the native DNA
sequence, but the difference was not significant, strongly
suggesting that the binding affinity of integrase is dependent upon
the 59-T:GCA-39 sequence in the target DNA (Fig. 3B).
Suppression of Retroviral Integration by Modified Target
Sequence DNAs
Modified substrate DNA (replaced i or replaced ii) was mixed
with an equal concentration of native target CD27 DNA and an
in vitro integration assay was performed. Unexpectedly, integration
into the native target DNA was significantly repressed in the
presence of modified replaced i DNA (Fig. 4A, *P , 0.01). The
modified sequence DNA interfered with viral integration (Fig. 4B),
which is consistent with our previous report [7].
Discussion
The biochemical properties of interaction between HIV-1
integrase and its target DNA were investigated through the
development of a new in vitro integration assay using target gene
DNAs. We found that the target nucleotide sequence TGCA
located at the integration site appears to influence the integration
process. We also replaced nucleotides in the presumed stem
structure in the CD27 segment to examine whether inhibition of
secondary structure formation had an effect on integration. The
fact that replacing nucleotides in the presumed stem structure
resulted in a significant suppression of integration into in the target
segments suggests that the secondary structure formed by the
native CD27 sequence DNA renders the target segment more
accessible for integrase. By application of fluorescence resonance
energy transfer (FRET) Katz et al. previously noted the possibility
that the secondary structure may be formed by the target double-
stranded DNA during integration [13,14]. Indeed, figure 2B shows
the secondary structure anticipated by m-fold analysis of above
shown sequence [12], which revealed that the integration site
(indicated by a shaded box) was located at the corner of a loop
attached to a long stem structure. The replacement of bases was
anticipated to disrupt the stem of the presumed structure.
In addition, the fact that HIV preferably integrates into
transcriptionally active genes [1] suggests that the target segment
used in the present study, which is part of a gene involved in T cell
development, is probably transcriptionally active. As such, the
segment may therefore be accessible to DNA-binding proteins
such as transcription factors or components of the transcriptional
apparatus. It is also possible that the double strand in the target
segment may be rewound into a single strand following formation
of the loop-like structure by hybridization within the strand.
Therefore, it appears that both the focal nucleotides at the
Figure 1. Schematic illustrations of reported protocols for assessing in vitro integration. (A) ‘‘Mini-HIV-1’’ consisting of both the 59- and 39-
ends of HIV-1 proviral DNA is incubated with substrate lambda phage DNA (Bushman). (B) The in vitro integration assay described in the present our
report, which uses the tandem LTR (U3-R-U5-U3-R-U5) cDNA sequence of HIV-1. The tandem LTR is incubated with a substrate DNA consisting of 6
repeats of the CD27 gene target sequence identified as the in vivo HIV-1 integration site.
doi:10.1371/journal.pone.0049960.g001
Target Sequence of HIV-1 Integration
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integration site and the secondary structure generated by the
sequences flanking the integration site play a role in determining
the accessibility for integrase.
The QCM assay was used to directly determine which segment
of the target DNA sequence is preferentially bound by integrase
[15]. The results of QCM assays demonstrated that approximately
twice as much integrase was bound to CD27 DNA, including the
TGCA sequence, than was bound to the modified DNAs we
examined. Studies indicate that HIV-1 proviruses and other
proviruses such as HTLV-I and MLV share the dinucleotide motif
59-CA and 59-TG at their termini [16]. It is therefore likely that
interaction between the TGCA sequence in the target DNA and
the viral DNAs is a common occurrence.
In our previous study [7], we found that the modified target
sequence favored in HIV-1 cDNA integration affected integration
into the native target sequence. The cause of this in vitro
Figure 2. In vitro integration site in the target CD27 sequence DNA. (A) Percentage of integration at individual sites in the target CD27
sequence DNA. A shaded box indicates the frequent integration site in the in vitro integration assay in (B). (B) Anticipated secondary structure
formation in the target CD27 sequence DNA as determined by m-fold analysis. An arrowhead indicates the integration site in the previously reported
target nucleotide (Genbank Accession No. AF038363) [6]. Blue, green, and red arrows represent mutations of replaced i, replaced ii, and replaced iii,
respectively. Gibbs’ free energy is given by DG=DH -TDS, where DG=27.34 kcal/mol at 37uC, DH=2114.80 kcal/mol, DS=2346.4 cal/(K?mol),
Tm= 58.1uC under ionic conditions in which [Mg
2+] = 1.0 mol/L. The same concentration of Mg2+ was used in the in vitro integration assay. A shaded
box indicates the frequent integration site in the in vitro integration assay. (X) Percentage of integration at various sites in the target CD27 sequence
DNA, control random DNA, and modified DNAs (replaced i and replaced ii). Length ratio percentage indicates the ratio of percentage integration into
the target sequence DNA to that of integration into the whole substrate DNA. The percentage integration into the CD27 sequence DNA was
significantly higher than that into random sequence and replaced DNAs (i) and (ii) (*, **, ***, P , 0.01). (D) Percentage of integration into the target
sequence DNA relative to the percentage of integration into the whole substrate DNA (*P , 0.01 vs. target CD27 DNA segment). The site of the
nucleotide replacement in the Replaced (iii) segment is shown by the red arrow in Fig. 2A. Letters next to the arrows in 2A denote the replacement
nucleotides. Results are representative of 5 independent assays. The means 6 SD are shown. The notations (iii)+(i) and (iii)+ (ii) signify segments with
both types of modification.
doi:10.1371/journal.pone.0049960.g002
Target Sequence of HIV-1 Integration
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Figure 3. Assessment of integrase binding using a quartz crystal microbalance. (A) Scheme depicting the quartz crystal microbalance
assay. DNA is deposited on the electrode. (B) Representative graphs of results of assays using target CD27 DNA and replaced i DNA. Downward
arrows represent the frequency (Hz) at the plateau phase after integrase binding. (C) Graph showing the weight of integrase bound to CD27 target,
random, replaced i, and replaced ii DNAs which were fixed onto the QCM sensor chip. (*, **P , 0.01). Results are representative of 5 independent
assays. The means 6 SD are shown.
doi:10.1371/journal.pone.0049960.g003
Figure 4. Decoy effect of the CD27 modified sequence. (A) The percentage of integration into the native target DNA was significantly
suppressed in the presence of the modified DNAs replaced i and replaced ii (*, **P , 0.01). Results are representative of 5 independent assays. The
means 6 SD are shown. (B) Scheme depicting the proposed mechanism of the decoy effect of the modified DNA.
doi:10.1371/journal.pone.0049960.g004
Target Sequence of HIV-1 Integration
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interference, termed the decoy effect, remains unclear. One plausible
explanation is that the modified DNA segment has some affinity
for the HIV-1 integrase-cDNA complex, and that this low affinity
interferes with integration through competition. This possibility is
supported by QCM assay results indicating that the affinity of the
modified segments for the integrase complex is about half of that of
the native DNA segment. As a result, the modified sequence DNA
competes with the native DNA for integrase.
The CD27 antigen is involved in the activation of T cells and
plays a role in the infection of T cells by HIV-1. Integration of
HIV-1 into CD27 disrupts the CD27 translational region.
Integration into the genome of CD4+ T cells renders the host
cell unable to differentiate through the CD27 signal [17]. CD27
plays a supportive role in T(H)1 differentiation in vivo, without
modulating the classical T(H)2 response. In addition, CD27
instructs CD4+ T cells to provide help for the memory CD8+ T
cell response after protein immunization [18]. These observations
suggest that when HIV-1 integrates into CD27, the CD4+ T cell
help response is blunted, resulting in insufficient CD8+ cytotoxic T
cell-mediated removal of HIV-1–infected CD4+ T cells. Altered T
cell differentiation was shown to be associated with the loss of
CD27 in HIV-infected Indians [19]. HIV-1–specific memory
CD4+ T cells are phenotypically less mature. After highly active
anti-retroviral therapy (HAART), HIV-1–specific CD4+ T cells
are enriched for CD27+ CD28 (2)-expressing cells, a rare
phenotype, reflecting an early intermediate stage of differentiation
[20]. If integration into CD27 affects the differentiation or
activation of host CD4+ T cells, such arrest may contribute to
the observed lack of help by CD4+ T cells and the development of
AIDS.
Further detailed studies are needed to more completely
elucidate the precise biochemical properties of in vitro retroviral
integration. It is possible that such studies may reveal the existence
of a more favored target segment. The findings arising from the
current study may help facilitate a greater understanding of
retroviral integration.
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